All Articles on COVID-19 Vaccine

• 
  NIH-Moderna COVID-19 vaccine receives FDA Emergency Use Authorization

  The investigational vaccine that KPWHRI’s team first tested shows an efficacy rate of about 94% as research continues.
• 
  The next stage in COVID-19 vaccine research

  In a Viewpoint for JAMA, KPWHRI’s Dr. Mike Jackson plans ahead to meet the challenges of continuing to evaluate new vaccines.